|
|
Article: Endovasc Announces Plans To Jump To Phase III Liprostin Clinical Trials.
- Article from:
- Blood Weekly
- Article date:
- May 24, 2001
CopyrightCOPYRIGHT 2001 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2001 MAY 24 - (NewsRx.com & NewsRx.net) --
Endovasc Ltd. Inc. (ENDV) has announced plans to move directly into Phase III human trials with critical limb ischemic patients.
Having demonstrated very successful results from the recently concluded animal studies as well as a significant safety profile in Phase I human trials in healthy volunteers, Endovasc Ltd. Inc. has determined it will proceed with Phase III, i.e., the last phase of Investigative New Drug (IND) clinical development, as recommended by the U.S. Food and Drug Administration at their October 1999 Pre-Investigational New Drug Application (Pre-IND) meeting.
"When our Investigational ...